During the past decade, Damanhour Medical National Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Damanhour Medical National Institute" are "Bone Fracture" (1 trials) and "Diabetic Patients" (1 trials). Many other conditions were trialed in "Damanhour Medical National Institute" in a lesser frequency.

Most popular intervention types in "Damanhour Medical National Institute" are "Drug" (2 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Glimepiride" (1 trials), "Metformin Retard 850 mg" (1 trials), "Omega 3 fatty acids 1000 mg per day + glimepiride 2 mg or 3 mg oral" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Damanhour Medical National Institute" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Damanhour Medical National Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Damanhour Medical National Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Damanhour Medical National Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".